Britain’s plan to raise NHS drug prices won’t bring back Lilly’s investment ⊕
found
a story from Politico EU ✅ › Politico EU
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Comments from medicines firm Eli Lilly will be a blow to British officials, who are in advanced negotiations with the Trump administration to secure tariff relief.